PDT Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-27,445
| Closed | -$1.92M | – | 949 |
|
2022
Q3 | $1.92M | Sell |
27,445
-10,499
| -28% | -$733K | 0.29% | 78 |
|
2022
Q2 | $2.55M | Buy |
+37,944
| New | +$2.55M | 0.22% | 120 |
|
2021
Q1 | – | Sell |
-2,129
| Closed | -$468K | – | 911 |
|
2020
Q4 | $468K | Buy |
+2,129
| New | +$468K | 0.03% | 459 |
|
2018
Q2 | – | Sell |
-24,015
| Closed | -$737K | – | 593 |
|
2018
Q1 | $737K | Sell |
24,015
-1,209
| -5% | -$37.1K | 0.02% | 397 |
|
2017
Q4 | $460K | Sell |
25,224
-42,976
| -63% | -$784K | 0.01% | 436 |
|
2017
Q3 | $798K | Buy |
68,200
+13,500
| +25% | +$158K | 0.03% | 381 |
|
2017
Q2 | $200K | Buy |
+54,700
| New | +$200K | 0.01% | 483 |
|
2016
Q1 | – | Sell |
-18,600
| Closed | -$588K | – | 608 |
|
2015
Q4 | $588K | Hold |
18,600
| – | – | 0.08% | 267 |
|
2015
Q3 | $640K | Buy |
18,600
+9,648
| +108% | +$332K | 0.01% | 843 |
|
2015
Q2 | $282K | Buy |
+8,952
| New | +$282K | 0.01% | 1148 |
|